Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02HCU
|
||||
Former ID |
DIB006289
|
||||
Drug Name |
WEB-2347
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Allergy [ICD9: 995.3; ICD10:T78.4] | Terminated | [1] | ||
Company |
Boehringer Ingelheim Corp
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C25H28ClN5OS
|
||||
Canonical SMILES |
c12c(n3c(nnc3)CN=C2c2c(Cl)cccc2)sc2c1CC(C(=O)N(CCC)CCC)<br />C2
|
||||
CAS Number |
CAS 114800-19-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Platelet-activating factor receptor | Target Info | Modulator | [2] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Staphylococcus aureus infection | |||||
NetPath Pathway | IL5 Signaling Pathway | ||||
Leptin Signaling Pathway | |||||
Reactome | Class A/1 (Rhodopsin-like receptors) | ||||
G alpha (q) signalling events | |||||
Interferon gamma signaling | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Small Ligand GPCRs | |||||
Interferon gamma signaling | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001720) | ||||
REF 2 | WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs. J Lipid Mediat. 1991 Jul-Aug;4(1):39-44. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.